Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins (original) (raw)

. 1996 Mar;148(3):897–909.

Abstract

Eosinophils, neutrophils, and mast cells have all been implicated in the pathogenesis of bullous pemphigoid (BP). To comparatively characterize the involvement of these cells in BP, 10 lesional skin biopsy specimens were identified retrospectively and studied for tissue localization of eosinophil, neutrophil, and mast cell granule proteins. Subsequently, multiple skin biopsies of lesions in various developmental stages were obtained from 3 patients with untreated BP. Involved and uninvolved skin specimens were also obtained from 2 patients. Using indirect immunofluorescence, retrospectively identified lesions showed eosinophils and extracellular granule protein deposition prominently in areas of blistering. Evolving lesions showed eosinophil granule protein deposition in all stages but was most marked in early erythematous and prebullous (urticarial) lesions and was minimal in uninvolved skin. Vascular cell adhesion molecule-1, E-selectin, and P-selectin were detected on vessels and very late activation antigen-4 was detected on mononuclear cells and eosinophils by immunoperoxidase staining of lesions. Eosinophil granule proteins were increased in the peripheral blood, urine, and blister fluid. Blister fluids caused increased eosinophil survival that was inhibited by antibodies to interleukin-5 and interleukin-3. Although neutrophil and mast cell infiltration was observed, extracellular granule protein deposition from these cells was minimal except in two specimens. These results demonstrate that eosinophils infiltrate and deposit granule proteins early in the development of BP lesions, that eosinophil-activating cytokines are present in blister fluid, and that eosinophil-selective adhesion molecules are present. These studies strongly support a role for eosinophils in blister formation in BP.

897

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Ghazaleh R. I., Dunnette S. L., Loegering D. A., Checkel J. L., Kita H., Thomas L. L., Gleich G. J. Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol. 1992 Dec;52(6):611–618. doi: 10.1002/jlb.52.6.611. [DOI] [PubMed] [Google Scholar]
  2. Bergstresser P. R., Tigelaar R. E., Tharp M. D. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol. 1984 Sep;83(3):214–218. doi: 10.1111/1523-1747.ep12263584. [DOI] [PubMed] [Google Scholar]
  3. Bochner B. S., Luscinskas F. W., Gimbrone M. A., Jr, Newman W., Sterbinsky S. A., Derse-Anthony C. P., Klunk D., Schleimer R. P. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med. 1991 Jun 1;173(6):1553–1557. doi: 10.1084/jem.173.6.1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carlo J. R., Gammon W. R., Sams W. M., Jr, Ruddy S. Demonstration of the complement regulating protein, beta 1H, in skin biopsies from patients with bullous pemphigoid. J Invest Dermatol. 1979 Dec;73(6):551–553. doi: 10.1111/1523-1747.ep12541572. [DOI] [PubMed] [Google Scholar]
  5. Czech W., Schaller J., Schöpf E., Kapp A. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J Am Acad Dermatol. 1993 Aug;29(2 Pt 1):210–215. doi: 10.1016/0190-9622(93)70170-x. [DOI] [PubMed] [Google Scholar]
  6. Dahl M. V., Falk R. J., Carpenter R., Michael A. F. Deposition of the membrane attack complex of complement in bullous pemphigoid. J Invest Dermatol. 1984 Feb;82(2):132–135. doi: 10.1111/1523-1747.ep12259679. [DOI] [PubMed] [Google Scholar]
  7. Dubertret L., Bertaux B., Fosse M., Touraine R. Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol. 1980 Dec;103(6):615–624. doi: 10.1111/j.1365-2133.1980.tb01683.x. [DOI] [PubMed] [Google Scholar]
  8. Dvorak A. M., Mihm M. C., Jr, Osage J. E., Kwan T. H., Austen K. F., Wintroub B. U. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol. 1982 Feb;78(2):91–101. doi: 10.1111/1523-1747.ep12505711. [DOI] [PubMed] [Google Scholar]
  9. Filley W. V., Ackerman S. J., Gleich G. J. An immunofluorescent method for specific staining of eosinophil granule major basic protein. J Immunol Methods. 1981;47(2):227–238. doi: 10.1016/0022-1759(81)90123-x. [DOI] [PubMed] [Google Scholar]
  10. Gammon W. R., Merritt C. C., Lewis D. M., Sams W. M., Jr, Carlo J. R., Wheeler C. E., Jr An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol. 1982 Apr;78(4):285–290. doi: 10.1111/1523-1747.ep12507222. [DOI] [PubMed] [Google Scholar]
  11. Gammon W. R., Merritt C. C., Lewis D. M., Sams W. M., Jr, Wheeler C. E., Jr, Carlo J. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method. J Invest Dermatol. 1981 Jun;76(6):514–522. doi: 10.1111/1523-1747.ep12521246. [DOI] [PubMed] [Google Scholar]
  12. Gleich G. J., Adolphson C. R., Leiferman K. M. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993;44:85–101. doi: 10.1146/annurev.me.44.020193.000505. [DOI] [PubMed] [Google Scholar]
  13. Goldstein S. M., Wasserman S. I., Wintroub B. U. Mast cell and eosinophil mediated damage in bullous pemphigoid. Immunol Ser. 1989;46:527–545. [PubMed] [Google Scholar]
  14. Graber N., Gopal T. V., Wilson D., Beall L. D., Polte T., Newman W. T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1. J Immunol. 1990 Aug 1;145(3):819–830. [PubMed] [Google Scholar]
  15. Iryo K., Tsuda S., Sasai Y. Ultrastructural aspects of infiltrated eosinophils in bullous pemphigoid. J Dermatol. 1992 Jul;19(7):393–399. doi: 10.1111/j.1346-8138.1992.tb03247.x. [DOI] [PubMed] [Google Scholar]
  16. Johnston N. W., Bienenstock J. Abolition of non-specific fluorescent staining of eosinophils. J Immunol Methods. 1974 Mar;4(2):189–194. doi: 10.1016/0022-1759(74)90060-x. [DOI] [PubMed] [Google Scholar]
  17. Jordon R. E., Nordby J. M., Milstein H. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med. 1975 Nov;86(5):733–740. [PubMed] [Google Scholar]
  18. Kita H., Ohnishi T., Okubo Y., Weiler D., Abrams J. S., Gleich G. J. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991 Sep 1;174(3):745–748. doi: 10.1084/jem.174.3.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Korman N. Bullous pemphigoid. J Am Acad Dermatol. 1987 May;16(5 Pt 1):907–924. doi: 10.1016/s0190-9622(87)70115-7. [DOI] [PubMed] [Google Scholar]
  20. Krenik K. D., Kephart G. M., Offord K. P., Dunnette S. L., Gleich G. J. Comparison of antifading agents used in immunofluorescence. J Immunol Methods. 1989 Feb 8;117(1):91–97. doi: 10.1016/0022-1759(89)90122-1. [DOI] [PubMed] [Google Scholar]
  21. Leiferman K. M., Fujisawa T., Gray B. H., Gleich G. J. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest. 1990 May;62(5):579–589. [PubMed] [Google Scholar]
  22. Maddox D. E., Butterfield J. H., Ackerman S. J., Coulam C. B., Gleich G. J. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein. J Exp Med. 1983 Oct 1;158(4):1211–1226. doi: 10.1084/jem.158.4.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miyasato M., Tsuda S., Kasada M., Iryo K., Sasai Y. Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid. Arch Dermatol Res. 1989;281(5):304–309. doi: 10.1007/BF00412972. [DOI] [PubMed] [Google Scholar]
  24. Moqbel R., Levi-Schaffer F., Kay A. B. Cytokine generation by eosinophils. J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1183–1188. doi: 10.1016/0091-6749(94)90330-1. [DOI] [PubMed] [Google Scholar]
  25. Moy J. N., Gleich G. J., Thomas L. L. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J Immunol. 1990 Oct 15;145(8):2626–2632. [PubMed] [Google Scholar]
  26. Naito K., Morioka S., Ogawa H. The pathogenic mechanisms of blister formation in bullous pemphigoid. J Invest Dermatol. 1982 Nov;79(5):303–306. doi: 10.1111/1523-1747.ep12500082. [DOI] [PubMed] [Google Scholar]
  27. Pehamberger H., Gschnait F., Konrad K., Holubar K. Bullous pemphigoid, herpes gestationis and linear dermatitis herpetiformis: circulating anti-basement membrane zone antibodies; in vitro studies. J Invest Dermatol. 1980 Feb;74(2):105–108. doi: 10.1111/1523-1747.ep12520017. [DOI] [PubMed] [Google Scholar]
  28. Perez G. L., Peters M. S., Reda A. M., Butterfield J. H., Peterson E. A., Leiferman K. M. Mast cells, neutrophils, and eosinophils in prurigo nodularis. Arch Dermatol. 1993 Jul;129(7):861–865. [PubMed] [Google Scholar]
  29. Peters M. S., Schroeter A. L., Kephart G. M., Gleich G. J. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol. 1983 Jul;81(1):39–43. doi: 10.1111/1523-1747.ep12538380. [DOI] [PubMed] [Google Scholar]
  30. Provost T. T., Tomasi T. B., Jr Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest. 1973 Jul;52(7):1779–1787. doi: 10.1172/JCI107359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sams W. M., Jr, Gammon W. R. Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol. 1982 Apr;6(4 Pt 1):431–452. doi: 10.1016/s0190-9622(82)70036-2. [DOI] [PubMed] [Google Scholar]
  32. Schmidt-Ullrich B., Rule A., Schaumburg-Lever G., Leblanc C. Ultrastructural localization of in vivo-bound complement in bullous pemphigoid. J Invest Dermatol. 1975 Aug;65(2):217–219. doi: 10.1111/1523-1747.ep12598218. [DOI] [PubMed] [Google Scholar]
  33. Silberstein D. S., Austen K. F., Owen W. F., Jr Hemopoietins for eosinophils. Glycoprotein hormones that regulate the development of inflammation in eosinophilia-associated disease. Hematol Oncol Clin North Am. 1989 Sep;3(3):511–533. [PubMed] [Google Scholar]
  34. Ståhle-Bäckdahl M., Inoue M., Guidice G. J., Parks W. C. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest. 1994 May;93(5):2022–2030. doi: 10.1172/JCI117196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tamaki K., So K., Furuya T., Furue M. Cytokine profile of patients with bullous pemphigoid. Br J Dermatol. 1994 Jan;130(1):128–129. doi: 10.1111/j.1365-2133.1994.tb06902.x. [DOI] [PubMed] [Google Scholar]
  36. Tsuda S., Miyasato M., Iryo K., Nakama T., Kato K., Sasai Y. Eosinophil phenotypes in bullous pemphigoid. J Dermatol. 1992 May;19(5):270–279. doi: 10.1111/j.1346-8138.1992.tb03224.x. [DOI] [PubMed] [Google Scholar]
  37. Varigos G. A., Morstyn G., Vadas M. A. Bullous pemphigoid blister fluid stimulates eosinophil colony formation and activates eosinophils. Clin Exp Immunol. 1982 Dec;50(3):555–562. [PMC free article] [PubMed] [Google Scholar]
  38. Wagner J. M., Bartemes K., Vernof K. K., Dunnette S., Offord K. P., Checkel J. L., Gleich G. J. Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta. 1993 Nov-Dec;14(6):671–681. doi: 10.1016/s0143-4004(05)80384-4. [DOI] [PubMed] [Google Scholar]
  39. Wintroub B. U., Mihm M. C., Jr, Goetzl E. J., Soter N. A., Austen K. F. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med. 1978 Feb 23;298(8):417–421. doi: 10.1056/NEJM197802232980803. [DOI] [PubMed] [Google Scholar]
  40. Wintroub B. U., Wasserman S. I. The molecular pathogenesis of bullous pemphigoid. Clin Dermatol. 1987 Jan-Mar;5(1):126–134. doi: 10.1016/0738-081x(87)90057-5. [DOI] [PubMed] [Google Scholar]
  41. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med. 1988 May 1;167(5):1737–1742. doi: 10.1084/jem.167.5.1737. [DOI] [PMC free article] [PubMed] [Google Scholar]